Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecules as therapeutic drugs for Alzheimer's disease
Darryll Oliver, P. Hemachandra Reddy
Molecular and Cellular Neuroscience (2019) Vol. 96, pp. 47-62
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
P. Hemachandra Reddy, Darryll Oliver
Cells (2019) Vol. 8, Iss. 5, pp. 488-488
Open Access | Times Cited: 376
Defective mitophagy in Alzheimer’s disease
Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy
Ageing Research Reviews (2020) Vol. 64, pp. 101191-101191
Open Access | Times Cited: 262
Oxidative Stress and Dementia in Alzheimer’s Patients: Effects of Synbiotic Supplementation
Alyne Mendonça Marques Ton, Bianca Prandi Campagnaro, Gisela Aleixo Alves, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 166
Mitochondrial dynamics and transport in Alzheimer's disease
Padraig J. Flannery, Eugenia Trushina
Molecular and Cellular Neuroscience (2019) Vol. 98, pp. 109-120
Open Access | Times Cited: 165
SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
R. Manjula, Kumari Anuja, Francisco J. Alcaı́n
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 142
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3739-3739
Open Access | Times Cited: 50
Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2977-2988
Open Access | Times Cited: 18
Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
Kyle C McGill Percy, Zhenguo Liu, Xin Qi
Neurotherapeutics (2025), pp. e00525-e00525
Open Access | Times Cited: 5
Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment
Qian Jiang, Jie Yin, Jiashun Chen, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 130
Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease
Peng Yang, Dongyu Sheng, Qian Guo, et al.
Biomaterials (2020) Vol. 238, pp. 119844-119844
Closed Access | Times Cited: 104
Are mitochondria the main contributor of reactive oxygen species in cells?
Yufeng Zhang, Hoi Shan Wong
Journal of Experimental Biology (2021) Vol. 224, Iss. 5
Open Access | Times Cited: 85
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease
Rishika Dhapola, Phulen Sarma, Bikash Medhi, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 535-555
Closed Access | Times Cited: 73
Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and application
Jiajia Xu, Wei Du, Yunhe Zhao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2778-2789
Open Access | Times Cited: 68
Mitochondrial dysfunction, mitophagy, and role of dynamin‐related protein 1 in Alzheimer's disease
Vijay Krishna Medala, Buchaiah Gollapelli, Saikat Dewanjee, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 4, pp. 1120-1135
Closed Access | Times Cited: 60
Mitochondrial quality control in health and cardiovascular diseases
Asli E. Atici, Timothy R. Crother, Magali Noval Rivas
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 25
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Mitochondrial fission and fusion in neurodegenerative diseases:Ca2+ signalling
Xuan Liu, Tianjiao Li, Xiaoming Tu, et al.
Molecular and Cellular Neuroscience (2025), pp. 103992-103992
Closed Access | Times Cited: 1
Triphenylphosphonium (TPP)‐Based Antioxidants: A New Perspective on Antioxidant Design
Jiayao Wang, Jiaqi Q. Li, Yumei Xiao, et al.
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 404-410
Closed Access | Times Cited: 65
The role of amyloids in Alzheimer's and Parkinson's diseases
Parveen Salahuddin, Munazza Fatima, Vladimir N. Uversky, et al.
International Journal of Biological Macromolecules (2021) Vol. 190, pp. 44-55
Open Access | Times Cited: 55
Mitochondrial superoxide/hydrogen peroxide: An emerging therapeutic target for metabolic diseases
Jialong Yan, Jinyong Jiang, Lu He, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 33-42
Closed Access | Times Cited: 52
Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Yi Sun, Jiaxuan Huang, Yufei Chen, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104172-104172
Open Access | Times Cited: 51
Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia
Noemí Esteras, Olga Kopach, Marta Maiolino, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 2, pp. 318-338
Open Access | Times Cited: 51
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1257-1257
Open Access | Times Cited: 47
Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions
John Onyebuchi Ogbodo, Chinazom Precious Agbo, Ugochi Olivia Njoku, et al.
Current Aging Science (2021) Vol. 15, Iss. 1, pp. 2-25
Closed Access | Times Cited: 46
Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
Gurjit Kaur Bhatti, Anshika Gupta, Paras Pahwa, et al.
Biomedical Journal (2022) Vol. 45, Iss. 5, pp. 733-748
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top